Closure of Trading Window
Filed with BSE · · 1 page · English
Summary by 6ix AI
Titan Biotech Limited has announced the closure of its trading window. This closure is in accordance with SEBI regulations and the company's insider trading code. The date for the board meeting to approve these results will be communicated later.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Office: 903-909. 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi-110034, India Telephone no.: 011-27355742, 71239900(44 Lines), CIN: L74999RJ1992PLC013387 ____________________________________________________________________________________ Date: 26/03/2026 Sub: Intimation for Closure of Trading Window Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with the Compan
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Feb 13 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2025
- Titan Biotech Limited Press Release Feb 12 2026
- Titan Biotech Limited Press Release Feb 10 2026
Later from Titan Biotech
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Titan Biotech Limited Press Release Apr 04 2026
- Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Titan Biotech Limited Press Release Apr 06 2026
- Titan Biotech Limited Press Release Apr 23 2026
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech